Evaluation of Comfort With Xibrom (Bromfenac Ophthalmic Solution)0.09% and Nevanac (Nepafenac Ophthalmic Suspension) 0.1% Following Selective Laser Trabeculoplasty (SLT)

PHASE4CompletedINTERVENTIONAL
Enrollment

25

Participants

Timeline

Start Date

January 31, 2009

Primary Completion Date

June 30, 2009

Study Completion Date

June 30, 2009

Conditions
Intraocular Pressure
Interventions
DRUG

Xibrom

Xibrom: two times a day for seven days in the first eye.

DRUG

Nevanac

Nevanac: three times a day for seven days in the second eye.

Trial Locations (1)

48152

Coburn-Kleinfeldt Eye Clinic, 3340 6 Mile Rd Livonia

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Bp Consulting, Inc

NETWORK

NCT00828477 - Evaluation of Comfort With Xibrom (Bromfenac Ophthalmic Solution)0.09% and Nevanac (Nepafenac Ophthalmic Suspension) 0.1% Following Selective Laser Trabeculoplasty (SLT) | Biotech Hunter | Biotech Hunter